Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide

Anti-Cancer Drugs

Volumn 21, Issue 10, 2010, Pages 963-967

  Tseng, Han Min ^a   Kuo, Lu Ting ^d   Lien, Huang Chun ^c   Liu, Kao Lang ^d   Liu, Mu Tai ^e,f   Huang, Chao Yuan ^b,f  

^a Department of Surgery   (Taiwan)

^b Division of Radiation Oncology   (Taiwan)

^c Department of Pathology ^*  (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Concomitant chemoradiotherapy; Intraspinal glioblastoma multiforme; Temozolomide; Total resection

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CERVICAL SPINAL CORD; FATALITY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOPSY; CERVICAL VERTEBRAE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FATAL OUTCOME; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROSURGICAL PROCEDURES; RADIOTHERAPY; SPINAL CORD NEOPLASMS;

EID: 78650043389     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32833f2a09     Document Type: Article

References (23)

1. Stein BM. Surgery of intramedullary spinal cord tumors. Clin Neurosurg 1979; 26:529-542.
2. Andrews AA, Enriques L, Renaudin J, Tomiyasu U. Spinal intramedullary glioblastoma with intracranial seeding. Report of a case. Arch Neurol 1978; 35:244-245.
3. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and longterm follow-up evaluation in 164 children and young adults. J Neurosurg 2000; 93:183-193.
4. Santi M, Mena H, Wong K, Koeller K, Olsen C, Rushing EJ. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases. Cancer 2003; 98:554-561.
5. McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 2008; 63:55-60.
6. Kuo LT, Kuo KT, Lee MJ, Wei CC, Scaravilli F, Tsai JC, et al. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors. Int J Cancer 2009; 124:2872-2879.
7. Mahoney FI, Barthel D. Functional evaluation: the Barthel index. Md State Med J 1965; 14:56-61.
8. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud 1988; 10:61-63.
9. Matsumoto T, Urasaki E, Soejima Y, Nakano Y, Yokota A, Nishizawa S. Cervical intramedullary glioblastoma: report of a long-term survival case and a review of the literature. J UOEH 2008; 30:413-420.
10. Stupp R, Hegi ME, MasonWP,Van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10:459-466.
11. Strik HM, Effenberger O, Schäfer O, Risch U, Wickboldt J, Meyermann R. A case of spinal glioblastoma multiforme: immunohistochemical study and review of the literature. J Neurooncol 2000; 50:239-243.
12. Koeller KK, Rosenblum RS, Morrison AL. Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 2000; 20:1721-1749.
13. Louis DN, Ohgaki H,Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109.
14. Jallo GI, Freed D, Epstein F. Intramedullary spinal cord tumors in children. Childs Nerv Syst 2003; 19:641-649.
15. Ciappetta P, Salvati M, Capoccia G, Artico M, Raco A, Fortuna A. Spinal glioblastomas: report of seven cases and review of the literature. Neurosurgery 1991; 28:302-306.
16. Linstadt DE, Wara WM, Leibel SA, Gutin PH, Wilson CB, Sheline GE. Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys 1989; 16:1397-1403.
17. Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-996.
18. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004; 10:1871-1874.
19. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008; 26:2192-2197.
20. Hegi ME, Liu L, Herman JG, Stupp R,WickW,Weller M, et al. Correlation of O-6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 2008; 26:4189-4199.
21. Hegi ME, Diserens AC, Gorlia T, Hamou MF, De Tribolet N,Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352:997-1003.
22. Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, et al. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin Cancer Res 2009; 15:6683-6693.
23. Blough MD, Beauchamp DC,Westgate MR, Kelly JJ, Cairncross JG. Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma. J Neurooncol 2010; [Epub ahead of print] doi: 10.1007/s11060-010-0283-9.